The JUPITER Trial: Responding to the Critics

This publication has 34 references indexed in Scilit:

• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
  The Lancet, 2010
• C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
  The Lancet, 2010
• Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
  Circulation, 2009
• Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population
  JACC, 2009
• Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
  Circulation: Cardiovascular Quality and Outcomes, 2009
• Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
  Diabetes Care, 2009
• The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
  BMJ, 2009
• A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
  New England Journal of Medicine, 2009
• Stopping or Reporting Early for Positive Results in Randomized Clinical Trials: The National Cancer Institute Cooperative Group Experience From 1990 to 2005
  Journal of Clinical Oncology, 2009
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
  New England Journal of Medicine, 2008